FR2884716B1 - Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires - Google Patents

Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires

Info

Publication number
FR2884716B1
FR2884716B1 FR0504069A FR0504069A FR2884716B1 FR 2884716 B1 FR2884716 B1 FR 2884716B1 FR 0504069 A FR0504069 A FR 0504069A FR 0504069 A FR0504069 A FR 0504069A FR 2884716 B1 FR2884716 B1 FR 2884716B1
Authority
FR
France
Prior art keywords
azithromycin
medicament
manufacture
treatment
ocular infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0504069A
Other languages
English (en)
Other versions
FR2884716A1 (fr
Inventor
Jacques Luyckx
Frederic Pilotaz
Pablo Goldschmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THEA LAB SA
Laboratoires Thea SAS
Original Assignee
THEA LAB SA
Laboratoires Thea SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35445697&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2884716(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by THEA LAB SA, Laboratoires Thea SAS filed Critical THEA LAB SA
Priority to FR0504069A priority Critical patent/FR2884716B1/fr
Priority to JOP/2006/0102A priority patent/JO3448B1/ar
Priority to TW095113740A priority patent/TWI430799B/zh
Priority to ARP060101560A priority patent/AR053591A1/es
Priority to PE2006000412A priority patent/PE20070157A1/es
Priority to MYPI20061806A priority patent/MY169533A/en
Priority to UAA200713028A priority patent/UA94708C2/ru
Priority to MX2007013054A priority patent/MX2007013054A/es
Priority to AU2006238595A priority patent/AU2006238595A1/en
Priority to US11/408,161 priority patent/US20060252711A1/en
Priority to CA002603833A priority patent/CA2603833A1/fr
Priority to SG201005298-3A priority patent/SG164382A1/en
Priority to BRPI0608375-7A priority patent/BRPI0608375A2/pt
Priority to EA200702295A priority patent/EA200702295A1/ru
Priority to EP06744536A priority patent/EP1877066A1/fr
Priority to PCT/IB2006/000963 priority patent/WO2006111844A1/fr
Priority to KR1020077027244A priority patent/KR20080008377A/ko
Priority to CN2006800135229A priority patent/CN101163486B/zh
Priority to JP2008507188A priority patent/JP2008536908A/ja
Publication of FR2884716A1 publication Critical patent/FR2884716A1/fr
Priority to IL186092A priority patent/IL186092A/en
Priority to TNP2007000370A priority patent/TNSN07370A1/fr
Priority to ZA200709872A priority patent/ZA200709872B/xx
Priority to NO20075943A priority patent/NO20075943L/no
Priority to MA30395A priority patent/MA29467B1/fr
Priority to HK08110973.2A priority patent/HK1119064A1/xx
Publication of FR2884716B1 publication Critical patent/FR2884716B1/fr
Application granted granted Critical
Priority to US12/555,509 priority patent/US20100069315A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
FR0504069A 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires Active FR2884716B1 (fr)

Priority Applications (26)

Application Number Priority Date Filing Date Title
FR0504069A FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
JOP/2006/0102A JO3448B1 (ar) 2005-04-22 2006-04-16 استخدام أزيثروميسين لتصنيع دواء لمعالجة إلتهابات العين
TW095113740A TWI430799B (zh) 2005-04-22 2006-04-18 阿齊黴素於製造治療砂眼之醫藥品的用途及製造該醫藥品之方法
ARP060101560A AR053591A1 (es) 2005-04-22 2006-04-20 Utilizacion de la acitromicina para la fabricacion de un medicamento detratamiento de las infecciones oculares
PE2006000412A PE20070157A1 (es) 2005-04-22 2006-04-20 Composicion farmaceutica oftalmica que comprende azitromicina
MYPI20061806A MY169533A (en) 2005-04-22 2006-04-20 Use of azithromycin for the manufacture of a medicament for treating ocular infections
EP06744536A EP1877066A1 (fr) 2005-04-22 2006-04-21 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires
EA200702295A EA200702295A1 (ru) 2005-04-22 2006-04-21 Применение азитромицина для изготовления лекарственного средства для лечения глазных инфекций
AU2006238595A AU2006238595A1 (en) 2005-04-22 2006-04-21 Use of azithromycin for the production of a medicament for treatment of ocular infections
US11/408,161 US20060252711A1 (en) 2005-04-22 2006-04-21 Method and medicament for treating ocular infections
CA002603833A CA2603833A1 (fr) 2005-04-22 2006-04-21 Utilisation de l'azithromycine pour la fabrication d'un medicament pour le traitement du trachome
SG201005298-3A SG164382A1 (en) 2005-04-22 2006-04-21 Use of azithromycin for the production of a medicament for treatment of ocular infections
BRPI0608375-7A BRPI0608375A2 (pt) 2005-04-22 2006-04-21 utilizacão de azitromicina, medicamento para o tratamento das conjuntivites bacterianas, processo de fabricacão de um medicamento de tratamento das infeccões oculares e acondicionamento para um medicamento para o tratamento das conjuntivites bacterianas
MX2007013054A MX2007013054A (es) 2005-04-22 2006-04-21 Uso de azitromicina para la fabricacion de un medicamento para tratamiento de infecciones oculares.
UAA200713028A UA94708C2 (ru) 2005-04-22 2006-04-21 Набор для лечения людей, страдающих трахомой, который содержит офтальмологическую композицию, изготовленную из азитромицина и среднецепочечных триглицеридов жирных кислот
PCT/IB2006/000963 WO2006111844A1 (fr) 2005-04-22 2006-04-21 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires
KR1020077027244A KR20080008377A (ko) 2005-04-22 2006-04-21 안구 감염 치료용 의약품 제조에 아지스로마이신을사용하는 방법
CN2006800135229A CN101163486B (zh) 2005-04-22 2006-04-21 阿奇霉素在生产用于治疗眼部感染的药物中的用途
JP2008507188A JP2008536908A (ja) 2005-04-22 2006-04-21 目の感染症の治療薬の製造のためのアジスロマイシンの利用
IL186092A IL186092A (en) 2005-04-22 2007-09-20 Use of azithromycin for the preparation of a topical eye medication for the treatment and prevention of tuberculosis infections by chalamydia trachomatis
TNP2007000370A TNSN07370A1 (fr) 2005-04-22 2007-10-01 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires
ZA200709872A ZA200709872B (en) 2005-04-22 2007-11-15 use of azithromycin for the production of a medicament for treatment of ocular infections
NO20075943A NO20075943L (no) 2005-04-22 2007-11-19 Anvendelse av azitromycin for fremstilling av et medikament for behandling av oyeinfeksjoner
MA30395A MA29467B1 (fr) 2005-04-22 2007-11-21 Utilisation de l'azithromycine pour la fabrication d'un medicament de traitement des infections oculaires
HK08110973.2A HK1119064A1 (en) 2005-04-22 2008-09-30 Use of azithromycin for the production of a medicament for treatment of ocular infections
US12/555,509 US20100069315A1 (en) 2005-04-22 2009-09-08 Method and medicament for treating ocular infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504069A FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires

Publications (2)

Publication Number Publication Date
FR2884716A1 FR2884716A1 (fr) 2006-10-27
FR2884716B1 true FR2884716B1 (fr) 2009-08-21

Family

ID=35445697

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0504069A Active FR2884716B1 (fr) 2005-04-22 2005-04-22 Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires

Country Status (25)

Country Link
US (2) US20060252711A1 (fr)
EP (1) EP1877066A1 (fr)
JP (1) JP2008536908A (fr)
KR (1) KR20080008377A (fr)
CN (1) CN101163486B (fr)
AR (1) AR053591A1 (fr)
AU (1) AU2006238595A1 (fr)
BR (1) BRPI0608375A2 (fr)
CA (1) CA2603833A1 (fr)
EA (1) EA200702295A1 (fr)
FR (1) FR2884716B1 (fr)
HK (1) HK1119064A1 (fr)
IL (1) IL186092A (fr)
JO (1) JO3448B1 (fr)
MA (1) MA29467B1 (fr)
MX (1) MX2007013054A (fr)
MY (1) MY169533A (fr)
NO (1) NO20075943L (fr)
PE (1) PE20070157A1 (fr)
SG (1) SG164382A1 (fr)
TN (1) TNSN07370A1 (fr)
TW (1) TWI430799B (fr)
UA (1) UA94708C2 (fr)
WO (1) WO2006111844A1 (fr)
ZA (1) ZA200709872B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098219A1 (fr) 2008-03-05 2009-09-09 PARI Pharma GmbH Compositions de macrolide ayant un goût et une stabilité améliorés
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001505855A (ja) * 1996-12-09 2001-05-08 ボシュ アンド ロム インコーポレイテッド 使い捨て可撓容器
ES2221127T5 (es) * 1997-12-02 2009-11-10 Pfizer Products Inc. Uso de acitromicina en el tratamiento topico de infecciones oculares.
US6861411B1 (en) * 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation

Also Published As

Publication number Publication date
ZA200709872B (en) 2008-09-25
US20100069315A1 (en) 2010-03-18
IL186092A0 (en) 2008-01-20
MX2007013054A (es) 2008-01-14
EA200702295A1 (ru) 2008-04-28
AU2006238595A1 (en) 2006-10-26
CN101163486A (zh) 2008-04-16
IL186092A (en) 2016-05-31
EP1877066A1 (fr) 2008-01-16
MA29467B1 (fr) 2008-05-02
TWI430799B (zh) 2014-03-21
CA2603833A1 (fr) 2006-10-26
CN101163486B (zh) 2011-11-30
UA94708C2 (ru) 2011-06-10
WO2006111844A1 (fr) 2006-10-26
AR053591A1 (es) 2007-05-09
SG164382A1 (en) 2010-09-29
MY169533A (en) 2019-04-22
JP2008536908A (ja) 2008-09-11
BRPI0608375A2 (pt) 2010-08-31
KR20080008377A (ko) 2008-01-23
TNSN07370A1 (fr) 2009-03-17
JO3448B1 (ar) 2020-07-05
NO20075943L (no) 2008-01-15
US20060252711A1 (en) 2006-11-09
TW200716142A (en) 2007-05-01
FR2884716A1 (fr) 2006-10-27
HK1119064A1 (en) 2009-02-27
PE20070157A1 (es) 2007-03-09

Similar Documents

Publication Publication Date Title
FR2891460B1 (fr) Utilisation d'au moins un compose de la famille des avermectines pour le traitement des pathologies ophtalmiques dues au demodex folliculorum.
FR13C0030I1 (fr) Compositions pour le traitement de troubles gastrointestinaux
FR2890306B1 (fr) Dispositif pour le traitement d'une poche vasculaire
FR22C1033I1 (fr) Utilisation de dihydroimidazolones pour le traitement des chiens
NO20053860D0 (no) COP 1 for behandling av inflammatorisk tarmsykdom.
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR2902324B1 (fr) Utilisation d'acide ellagique pour le traitement de la canitie
FR2902010B1 (fr) Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique
FR2887141B1 (fr) Orthese compressive tricotee du membre inferieur pour le traitement de l'insuffisance veineuse chronique
FR2880888B1 (fr) Utilisation d'aminodithiol en tant qu'agent reducteur pour la deformation permanente des cheveux
MA28640B1 (fr) Macrolides a liaison ester utiles pour le traitement d'infections microbiennes
MA28493B1 (fr) Sulfonamides destinés au traitement de troubles neurodégénératifs
FR2896422B1 (fr) Systeme de drainage pour le traitement de l'hydrocephalie
DE60105614D1 (de) Oxazinochinolone für die behandlung viraler infektionen
FR2906468B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
FR2884716B1 (fr) Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
FR2865403B1 (fr) Composition pour le traitement d'une pathologie associee a la msrv/herv-w
FR2924593B1 (fr) Plaque osseuse pour le traitement de l'extremite inferieure du cubitus
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
FR2887456B1 (fr) "composition pour le traitement de la dermite estivale"
FR2912059B1 (fr) Utilisation d'argiles pour le traitement de la maladie coeliaque
FR2926023B1 (fr) Utilisation d'une homoproteine de la famille bicoid pour le traitement du glaucome.
FR2883180B1 (fr) Utilisation de l'acetyl-leucine pour la preparation d'un medicament destine au traitement de troubles de l'equilibre
FR2868307B1 (fr) Utilisation de beta-endorphine pour le traitement des rides

Legal Events

Date Code Title Description
CJ Change in legal form
RM Correction of a material error
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19